NICK VIOLARIS LTD.Active
Key figures
Like most small UK companies, NICK VIOLARIS LTD. does not publish a profit and loss account (small company accounts (filleted)). The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2020/21–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Profit for the year | — | — | — | — | 3,803 |
| Cash at bank and in hand | 38,621 | 45,121 | 62,576 | 146,035 | 86,082 |
| Total assets | 334,522 | 294,685 | 321,211 | 359,670 | 299,717 |
| Total liabilities | — | — | — | — | 7,785 |
| Net assets / total equity | 323,592 | 284,700 | 306,624 | 328,129 | 291,932 |
| Average number of employees | 0 | 0 | 0 | 0 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the company in the year under review was that of medical consultancy.
As described in the company's latest filed accounts.
Summary: NICK VIOLARIS LTD.
Company
NICK VIOLARIS LTD. is a private limited company registered with Companies House under company number 04585508. It was incorporated on 8 Nov 2002. Its status is active. The registered office is in Eastbourne (BN20). Its nature of business (SIC 2007) is general medical practice activities (86210).
Accounts
The latest accounts in the database are for 2024/25 (period ending 28 Feb 2025); the company files small company accounts (filleted). Profit for the year was £3,803. Net assets were £291,932, down 11% on the previous year. Cash at bank and in hand was £86,082. Total assets were £299,717 and total liabilities £7,785. The company had an average of 0 employees. Figures are available for 5 financial years (2020/21–2024/25).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 30 Nov 2026. The next confirmation statement is due by 21 Nov 2026.